A randomized phase II study of radiation therapy, pemetrexed, and carboplatin with or without cetuximab in stage III non-small-cell lung cancer

Clin Lung Cancer. 2006 Jan;7(4):285-7. doi: 10.3816/CLC.2006.n.009.

Authors

Jeffrey A Bogart¹, Ramaswamy Govindan

Affiliation

¹ Department of Radiation Oncology, Upstate Medical University, Syracuse, NY, USA.

PMID: 16512986
DOI: 10.3816/CLC.2006.n.009

No abstract available

Publication types

Clinical Trial, Phase II
Randomized Controlled Trial

MeSH terms

Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carboplatin / administration & dosage
Carcinoma, Non-Small-Cell Lung / drug therapy
Carcinoma, Non-Small-Cell Lung / radiotherapy
Carcinoma, Non-Small-Cell Lung / therapy*
Cetuximab
Combined Modality Therapy
Glutamates / administration & dosage
Guanine / administration & dosage
Guanine / analogs & derivatives
Humans
Lung Neoplasms / drug therapy
Lung Neoplasms / radiotherapy
Lung Neoplasms / therapy*
Neoplasm Staging
Pemetrexed

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Glutamates
Pemetrexed
Guanine
Carboplatin
Cetuximab